HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ameliorative effect of acetylshikonin on cigarette smoke-induced lung inflammation in mice.

Abstract
Cigarette smoke exposure is the major cause of chronic obstructive pulmonary disease (COPD). Acetylshikonin was the active principle component of Purple Gromwell that show anti-oxidative and anti-inflammatory effect. However, no data are available to elucidate the protective effect of acetylshikonin on COPD. Acetylshikonin could attenuate smoke-induced lung pathological changes, tumor necrosis factor-α (TNF-α), interleukin-6 (IL-6), interleukin-1β (IL-1β), and monocyte chemoattractant protein 1 (MCP-1) productions, and tissue damages caused by oxidative stress. Furthermore, acetylshikonin was found to enhance the expression of Nrf2 and Nur77-mediated COX-2 in vivo and in vitro.
AuthorsXiao-Yan Zhang, Yu-Ping Jia, Qing Zhao, Wen-Ya Wang, Zhi Zhang, Wen Li, Li-Chao Sun
JournalJournal of Asian natural products research (J Asian Nat Prod Res) Vol. 22 Issue 11 Pg. 1078-1094 (Nov 2020) ISSN: 1477-2213 [Electronic] England
PMID31805776 (Publication Type: Journal Article)
Chemical References
  • Anthraquinones
  • Smoke
  • acetylshikonin
Topics
  • Animals
  • Anthraquinones
  • Inflammation (chemically induced, drug therapy)
  • Mice
  • Molecular Structure
  • Pneumonia
  • Smoke (adverse effects)
  • Smoking (adverse effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: